Patients deserve more treatment options. Our latest research, including never-before-seen data in #BladderCancer, demonstrate our ambition to transform care with novel targeted releasing systems: t.co/rwhFbqg6Kg #ESMO24 #JNJOncology t.co/H7bCP465p5